+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 3Years - 15Years
FEMALE
ID07780760

Comparing Nebulized Dexmedetomidine and Lidocaine to Reduce Postoperative Sore Throat in Children Undergoing Tonsillectomy A Randomized, Double-Blinded Trial

Led by Fayoum University Hospital · Updated on 2026-08-21

70

Participants Needed

1

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

This research compares the effects of nebulized Dexmedetomidine and nebulized Lidocaine on postoperative sore throat in children undergoing tonsillectomy. Tonsillectomy is a common day surgery for pediatric patients, but postoperative sore throat remains a frequent cause of discomfort and affects recovery. The study explores these two treatments to find better ways to reduce this sore throat after surgery. Participants are randomly assigned to one of two groups one receives nebulized Dexmedetomidine at 1 mcgkg, and the other receives nebulized Lidocaine 2% at 1 mgkg. Both treatments are given before surgery to assess their ability to reduce sore throat after the procedure. This trial uses a double-blinded, randomized design to compare these two aerosolized drugs. During the study, children will be monitored for the incidence and severity of postoperative sore throat immediately after surgery and at 4 hours postoperatively. Heart rate and blood pressure are checked frequently during surgery and up to 24 hours after. Researchers will also watch for any adverse effects during the first hour after surgery. The study is planned to run from September 2026 to February 2027.

CONDITIONS

Brief Title

Effect of Preoprative Nebulized Dexmedetomidine Compared to Nebulized Lidocaine in Attenuating Sore Throat Following Tonsillectomy In Childern.

Research Team

M

Mustafa Omar Rateb Abdelhafez, MBBCH

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here